1. Home
  2. MDGL vs KRG Comparison

MDGL vs KRG Comparison

Compare MDGL & KRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • KRG
  • Stock Information
  • Founded
  • MDGL 2011
  • KRG 1971
  • Country
  • MDGL United States
  • KRG United States
  • Employees
  • MDGL N/A
  • KRG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • KRG Real Estate Investment Trusts
  • Sector
  • MDGL Health Care
  • KRG Real Estate
  • Exchange
  • MDGL Nasdaq
  • KRG Nasdaq
  • Market Cap
  • MDGL 6.1B
  • KRG 5.0B
  • IPO Year
  • MDGL N/A
  • KRG 2004
  • Fundamental
  • Price
  • MDGL $314.31
  • KRG $22.53
  • Analyst Decision
  • MDGL Strong Buy
  • KRG Buy
  • Analyst Count
  • MDGL 9
  • KRG 8
  • Target Price
  • MDGL $420.63
  • KRG $27.25
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • KRG 1.5M
  • Earning Date
  • MDGL 08-06-2025
  • KRG 07-30-2025
  • Dividend Yield
  • MDGL N/A
  • KRG 4.80%
  • EPS Growth
  • MDGL N/A
  • KRG N/A
  • EPS
  • MDGL N/A
  • KRG 0.06
  • Revenue
  • MDGL $317,383,000.00
  • KRG $856,165,000.00
  • Revenue This Year
  • MDGL $286.17
  • KRG $3.11
  • Revenue Next Year
  • MDGL $64.17
  • KRG $3.08
  • P/E Ratio
  • MDGL N/A
  • KRG $370.62
  • Revenue Growth
  • MDGL N/A
  • KRG 3.94
  • 52 Week Low
  • MDGL $200.63
  • KRG $18.52
  • 52 Week High
  • MDGL $377.46
  • KRG $28.24
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • KRG 50.09
  • Support Level
  • MDGL $284.02
  • KRG $22.20
  • Resistance Level
  • MDGL $311.21
  • KRG $22.69
  • Average True Range (ATR)
  • MDGL 11.94
  • KRG 0.42
  • MACD
  • MDGL 2.74
  • KRG -0.05
  • Stochastic Oscillator
  • MDGL 100.00
  • KRG 35.61

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About KRG Kite Realty Group Trust

Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.

Share on Social Networks: